Suneva Medical
Suneva Medical was a San Diego-based medical aesthetics company that developed and sold FDA-cleared regenerative aesthetic products — including Bellafill, Silhouette Instalift, and Amplifine PRP — to dermatologists, plastic surgeons, and cosmetic practitioners. It was acquired by Tiger Aesthetics in 2025.
- Company typePrivate
- Founded2009
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Suneva Medical does
Suneva Medical, Inc. was a privately held medical aesthetics company founded in 2009 and headquartered in San Diego, California. It developed and commercialized a portfolio of FDA-cleared regenerative aesthetic products sold through a B2B distribution model targeting dermatologists, plastic surgeons, and cosmetic medicine practitioners. Its product portfolio centered on Bellafill, the first FDA-cleared 5-year biostimulatory dermal filler containing PMMA microspheres in bovine collagen gel for nasolabial fold and acne scar correction; Silhouette Instalift, the first absorbable suture FDA-cleared for cosmetic facial procedures providing minimally invasive lifting; and Amplifine PRP, a platelet-rich plasma platform for regenerative aesthetic treatments. The company also developed Viality, an enhanced-viability fat transfer system with a proprietary surfactant, and alloClae, a structural adipose tissue product for body aesthetics.
Suneva's business model relied on one-time product sales to licensed healthcare providers, with quote-based pricing and no disclosed subscription or recurring revenue component. Customer acquisition operated through a provider-locator model (the Sientra Surgeon Locator) and digital marketing channels including LinkedIn, Instagram, and a product website. The company funded growth through multiple venture and royalty-backed rounds between 2010 and 2020 — including financings from Essex Woodlands Healthcare Partners, Almirall, HealthCare Royalty Partners, and Polaris Partners — totaling approximately $175 million in disclosed capital.
In 2025, Suneva Medical was acquired by Tiger Aesthetics Medical, LLC, a strategic operating company in the regenerative aesthetics space. Following the transaction, Suneva's Bellafill, Silhouette Instalift, and Amplifine PRP product lines were integrated into Tiger Aesthetics' broader portfolio, which also includes Sientra silicone gel breast implants, Avéli cellulite treatment, alloClae, Viality, and breast tissue expanders (Dermaspan and AlloX2). Suneva continues to operate as a product brand within the Tiger Aesthetics commercial infrastructure.
Suneva Medical firmographics
Firmographics- Name
- Suneva Medical
- Legal name
- Suneva Medical, Inc.
- Website
- https://sunevamedical.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Suneva Medical was a San Diego-based medical aesthetics company that developed and sold FDA-cleared regenerative aesthetic products — including Bellafill, Silhouette Instalift, and Amplifine PRP — to dermatologists, plastic surgeons, and cosmetic practitioners. It was acquired by Tiger Aesthetics in 2025.
- Ownership category
- akta.pro rank
Suneva Medical industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industry
- Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)
Keywords
Where Suneva Medical is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Suneva Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations
Revenue model
- Medical Aesthetic Products: Revenue generated from selling proprietary aesthetic medical devices and products to healthcare providers. The portfolio includes dermal fillers, absorbable threads, PRP systems, and breast tissue expanders sold through provider networks.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Suneva Medical product offering
Product offeringCore offering
Suneva Medical developed, manufactured, and commercialized FDA-cleared medical aesthetic products for dermatologists, plastic surgeons, and cosmetic surgery practices. Its core portfolio included Bellafill (the first FDA-cleared 5-year biostimulatory dermal filler), Silhouette Instalift (an absorbable suture thread lift), and the Amplifine PRP platform, with products sold exclusively through a B2B provider network distribution model.
Product overview
Suneva Medical was a medical aesthetics company that developed and commercialized regenerative aesthetic products. Its portfolio included Bellafill (a biostimulatory filler), Silhouette Instalift (an absorbable thread lift device), and Amplifine PRP (a PRP platform). In 2025, Suneva Medical and its product portfolio were acquired by Tiger Aesthetics Medical, LLC. The products continue to be distributed and supported through Tiger Aesthetics' regenerative aesthetics portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Bellafill: FDA cleared 5-year biostimulatory filler for aesthetic treatments
- Silhouette Instalift
- Amplifine PRP
Products and services
- Bellafill
Companies that use Suneva Medical
Customer profileSegments2 records
Ideal customer profiles1 record
Suneva Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Suneva Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Tiger Aesthetics Medical, LLCcoreTiger Aesthetics Medical, LLC acquired Suneva Medical and its complete product portfolio including Bellafill, Silhouette Instalift, and Amplifine PRP products. This acquisition consolidated Suneva's regenerative aesthetics portfolio under Tiger Aesthetics' umbrella, combining complementary aesthetic device and filler offerings.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Suneva Medical competitors and assessment
Company assessmentBroad incumbents
- AbbVie (Allergan Aesthetics): Owns the Juvederm filler franchise and Botox, the dominant aesthetics portfolio globally. Directly comparable as the leading aesthetics medical device and injectable competitor with substantially greater scale and broader provider relationships than Suneva.
- Galderma: Markets the Restylane and Sculptra filler portfolios alongside Dysport neuromodulators. A direct competitor in the dermal filler and biostimulator (Sculptra) categories where Suneva's Bellafill competes.
- Merz Aesthetics: Sells Radiesse (calcium hydroxylapatite filler), Belotero, and Ultherapy in aesthetics. Directly comparable as a filler competitor with established provider relationships in dermatology and plastic surgery practices Suneva targets.
Direct peers
- Revance Therapeutics: Develops long-duration aesthetic injectables including Daxxify (long-lasting neuromodulator) and the RHA filler line. Directly comparable as a focused aesthetics injectable competitor pursuing differentiated longevity claims similar to Suneva's Bellafill positioning.
- Evolus: Specialty aesthetics company commercializing Jeuveau (prabotulinumtoxinA) and exploring broader injectable offerings. A comparable specialty aesthetics competitor targeting similar provider channels with a focused product strategy.
- Sinclair Pharma: Aesthetic medicine company that developed Silhouette Instalift before Suneva's distribution and was later acquired by Huadong Medicine. Directly comparable as a developer of thread lift and regenerative aesthetics products with overlapping technology focus.
- Sientra: Aesthetic medical device company specializing in breast implants and body contouring products. Now a sister brand under Tiger Aesthetics alongside Suneva, making it a directly comparable aesthetics device peer with shared distribution channels.
- Croma-Pharma: European-based aesthetics company offering hyaluronic acid fillers (Princess line), PRP systems, and regenerative aesthetics products. Directly comparable as a multi-product aesthetics company competing in fillers and regenerative platforms similar to Suneva's portfolio.
- Prollenium Medical Technologies: Specialty manufacturer of the Revanesse line of hyaluronic acid dermal fillers. A directly comparable specialty filler competitor targeting the same provider network Suneva serves with a focused aesthetics product strategy.
Regional players
- Hugel: South Korean aesthetics company with botulinum toxin (Botulax/Letybo) and dermal filler products. Comparable as a competitor in aesthetic injectables with growing international expansion that overlaps with Suneva's provider markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Suneva Medical social profiles
Digital presenceSuneva Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Suneva Medical leadership team
Management profileNumber of profiles
Profiles4 records
Suneva Medical funding detail
Funding detailFunding overview
Funding rounds10 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Suneva Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Suneva Medical
What does Suneva Medical do?
Suneva Medical developed, manufactured, and commercialized FDA-cleared medical aesthetic products for dermatologists, plastic surgeons, and cosmetic surgery practices. Its core portfolio included Bellafill (the first FDA-cleared 5-year biostimulatory dermal filler), Silhouette Instalift (an absorbable suture thread lift), and the Amplifine PRP platform, with products sold exclusively through a B2B provider network distribution model.
Is Suneva Medical a public or private company?
Suneva Medical is a private company. It is classified as corporate owned and is currently acquired.
When was Suneva Medical founded?
Suneva Medical was founded in 2009. It employs 101 to 250 people.
Where is Suneva Medical based?
Suneva Medical is headquartered in San Diego, United States, in the North America region.
How does Suneva Medical make money?
One revenue line is on record: medical Aesthetic Products.
Who are Suneva Medical's main competitors?
Broad incumbents on record are AbbVie (Allergan Aesthetics), Galderma and Merz Aesthetics. Direct peers are Revance Therapeutics, Evolus, Sinclair Pharma, Sientra, Croma-Pharma and Prollenium Medical Technologies. Hugel is listed as a regional player.
Does Suneva Medical have an API?
No public API is recorded for Suneva Medical.
What industry is Suneva Medical in?
Suneva Medical's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAKACAE, Cosmetic Dermatology (Aesthetic Injectables). Its NAICS code is 3391 and its SIC code is 3841.